Serum transforming growth factor-β1 change after neoadjuvant chemoradiation therapy is associated with postoperative pulmonary complications in esophageal cancer patients undergoing combined modality therapy

International Journal of Radiation Oncology Biology Physics

Volumn 93, Issue 5, 2015, Pages 1023-1031

  Lu, Shao Lun ^a   Hsu, Feng Ming ^a   Tsai, Chiao Ling ^a   Wu, Jian Kuan ^a   Lee, Jang Ming ^a   Huang, Pei Ming ^a   Hsu, Chih Hung ^a   Koong, Albert C ^b   Chang, Daniel T ^b   Chia Hsien Cheng, Jason ^a,c  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b STANFORD UNIVERSITY   (United States)

^c NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL ORGANS; CHEMORADIOTHERAPY; DOSIMETRY; MULTIVARIANT ANALYSIS; RADIOTHERAPY;

ACUTE RESPIRATORY DISTRESS SYNDROME; COMBINED MODALITY THERAPY; CONCURRENT CHEMORADIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; NEOADJUVANT CHEMORADIATION; PULMONARY COMPLICATIONS; TRANSFORMING GROWTH FACTORS;

BIOMARKERS;

ANTINEOPLASTIC AGENT; AXL PROTEIN; BONE MORPHOGENETIC PROTEIN 2; BONE MORPHOGENETIC PROTEIN 4; COLLAGENASE 3; EPIDERMAL GROWTH FACTOR RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR 2; FAM84B PROTEIN; FLUOROURACIL DERIVATIVE; GROWTH ARREST SPECIFIC PROTEIN 6; INTERSTITIAL COLLAGENASE; OSTEONECTIN; OSTEOPONTIN; PEPTIDES AND PROTEINS; PLATELET DERIVED GROWTH FACTOR ALPHA RECEPTOR; SOMATOMEDIN BINDING PROTEIN 3; TAXANE DERIVATIVE; TRANSCRIPTION FACTOR RUNX2; TRANSFORMING GROWTH FACTOR BETA1; TUMOR MARKER; UNCLASSIFIED DRUG; VASCULOTROPIN A; BRIDGED COMPOUND; FLUOROURACIL; TAXANE; TAXOID;

ADJUVANT CHEMORADIOTHERAPY; ADJUVANT THERAPY; ADULT; ADULT RESPIRATORY DISTRESS SYNDROME; ADVANCED CANCER; AGED; ARTICLE; ASSAY; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER SURGERY; CHEMICAL ANALYSIS; CLINICAL FEATURE; DISEASE ASSOCIATION; DOSIMETRY; ENZYME LINKED IMMUNOSORBENT ASSAY; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; ESOPHAGUS RESECTION; FEMALE; FORCED VITAL CAPACITY; HUMAN; INTENSITY MODULATED RADIATION THERAPY; LUNG COMPLICATION; MAJOR CLINICAL STUDY; MALE; MULTIMODALITY CANCER THERAPY; PNEUMONIA; POSTOPERATIVE COMPLICATION; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; PROXIMITY LIGATION ASSAY; RADIOTHERAPY PLANNING SYSTEM; ADVERSE EFFECTS; BLOOD; CARCINOMA, SQUAMOUS CELL; CHEMORADIOTHERAPY; ESOPHAGEAL NEOPLASMS; MIDDLE AGED; MULTIVARIATE ANALYSIS; PATHOLOGY; PROCEDURES; RESPIRATORY DISTRESS SYNDROME, ADULT;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BIOMARKERS, TUMOR; BRIDGED COMPOUNDS; CARCINOMA, SQUAMOUS CELL; CHEMORADIOTHERAPY; ENZYME-LINKED IMMUNOSORBENT ASSAY; ESOPHAGEAL NEOPLASMS; ESOPHAGECTOMY; FEMALE; FLUOROURACIL; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOADJUVANT THERAPY; PNEUMONIA; PROSPECTIVE STUDIES; RESPIRATORY DISTRESS SYNDROME, ADULT; TAXOIDS; TRANSFORMING GROWTH FACTOR BETA1;

EID: 84946733276     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2015.08.035     Document Type: Article

References (33)

1. P. van Hagen, M.C. Hulshof, J.J. van Lanschot, and et al. Preoperative chemoradiotherapy for esophageal or junctional cancer N Engl J Med 366 2012 2074 2084
2. J. Tepper, M.J. Krasna, D. Niedzwiecki, and et al. Phase III trial of trimodality therapy with cisplatin, fluorouracil, radiotherapy, and surgery compared with surgery alone for esophageal cancer: CALGB 9781 J Clin Oncol 26 2008 1086 1092
3. S.G. Urba, M.B. Orringer, A. Turrisi, and et al. Randomized trial of preoperative chemoradiation versus surgery alone in patients with locoregional esophageal carcinoma J Clin Oncol 19 2001 305 313
4. T.N. Walsh, N. Noonan, D. Hollywood, and et al. A comparison of multimodal therapy and surgery for esophageal adenocarcinoma N Engl J Med 335 1996 462 467
5. S.H. Bailey, D.A. Bull, D.H. Harpole, and et al. Outcomes after esophagectomy: A ten-year prospective cohort Ann Thorac Surg 75 2003 217 222 discussion 222
6. J. Inoue, R. Ono, D. Makiura, and et al. Prevention of postoperative pulmonary complications through intensive preoperative respiratory rehabilitation in patients with esophageal cancer Dis Esophagus 26 2013 68 74
7. C. Schieman, D.A. Wigle, C. Deschamps, and et al. Patterns of operative mortality following esophagectomy Dis Esophagus 25 2012 645 651
8. J. Wang, C. Wei, S.L. Tucker, and et al. Predictors of postoperative complications after trimodality therapy for esophageal cancer Int J Radiat Oncol Biol Phys 86 2013 885 891
9. H.K. Lee, A.A. Vaporciyan, J.D. Cox, and et al. Postoperative pulmonary complications after preoperative chemoradiation for esophageal carcinoma: Correlation with pulmonary dose-volume histogram parameters Int J Radiat Oncol Biol Phys 57 2003 1317 1322
10. S.L. Wang, Z. Liao, A.A. Vaporciyan, and et al. Investigation of clinical and dosimetric factors associated with postoperative pulmonary complications in esophageal cancer patients treated with concurrent chemoradiotherapy followed by surgery Int J Radiat Oncol Biol Phys 64 2006 692 699
11. F.M. Hsu, Y.C. Lee, J.M. Lee, and et al. Association of clinical and dosimetric factors with postoperative pulmonary complications in esophageal cancer patients receiving intensity-modulated radiation therapy and concurrent chemotherapy followed by thoracic esophagectomy Ann Surg Oncol 16 2009 1669 1677
12. S.L. Tucker, H.H. Liu, S. Wang, and et al. Dose-volume modeling of the risk of postoperative pulmonary complications among esophageal cancer patients treated with concurrent chemoradiotherapy followed by surgery Int J Radiat Oncol Biol Phys 66 2006 754 761
13. S. Fredriksson, W. Dixon, H. Ji, and et al. Multiplexed protein detection by proximity ligation for cancer biomarker validation Nat Methods 4 2007 327 329
14. S. Fredriksson, J. Horecka, O.T. Brustugun, and et al. Multiplexed proximity ligation assays to profile putative plasma biomarkers relevant to pancreatic and ovarian cancer Clin Chem 54 2008 582 589
15. S.T. Chang, J.M. Zahn, J. Horecka, and et al. Identification of a biomarker panel using a multiplex proximity ligation assay improves accuracy of pancreatic cancer diagnosis J Transl Med 7 2009 105
16. T.W. Rice, E.H. Blackstone, and V.W. Rusch 7th edition of the AJCC cancer staging manual: Esophagus and esophagogastric junction Ann Surg Oncol 17 2010 1721 1724
17. F.M. Hsu, J.M. Lee, P.M. Huang, and et al. Retrospective analysis of outcome differences in preoperative concurrent chemoradiation with or without elective nodal irradiation for esophageal squamous cell carcinoma Int J Radiat Oncol Biol Phys 81 2011 e593 e599
18. R. Chen, L. Li, and A.J. Butte AILUN: Reannotating gene expression data automatically Nat Methods 4 2007 879
19. J.C. Cheng, M.S. Graber, F.M. Hsu, and et al. High serum levels of vascular endothelial growth factor-A and transforming growth factor-beta1 before neoadjuvant chemoradiotherapy predict poor outcomes in patients with esophageal squamous cell carcinoma receiving combined modality therapy Ann Surg Oncol 21 2014 2361 2368
20. J.T. Lyman Complication probability as assessed from dose-volume histograms Radiat Res Suppl 8 1985 S13 S19
21. G.R. Bernard, A. Artigas, K.L. Brigham, and et al. The American-European consensus conference on ARDS: Definitions, mechanisms, relevant outcomes, and clinical trial coordination Am J Respir Crit Care Med 149 1994 818 824
22. M.K. Ferguson, A.D. Celauro, and V. Prachand Prediction of major pulmonary complications after esophagectomy Ann Thorac Surg 91 2011 1494 1500 discussion 1500-1491
23. J. Massague TGF-beta signal transduction Annu Rev Biochem 67 1998 753 791
24. A.B. Roberts, N.L. Thompson, U. Heine, and et al. Transforming growth factor-beta: Possible roles in carcinogenesis Br J Cancer 57 1988 594 600
25. D.R. Principe, J.A. Doll, J. Bauer, and et al. TGF-beta: Duality of function between tumor prevention and carcinogenesis J Natl Cancer Inst 106 2014 djt369
26. Y. Fukai, M. Fukuchi, N. Masuda, and et al. Reduced expression of transforming growth factor-beta receptors is an unfavorable prognostic factor in human esophageal squamous cell carcinoma Int J Cancer 104 2003 161 166
27. S.P. Sun, Y.N. Jin, H.P. Yang, and et al. Serum transforming growth factor-beta1 level reflects disease status in patients with esophageal carcinoma after radiotherapy World J Gastroenterol 13 2007 5267 5272
28. A.B. Kulkarni, and S. Karlsson Transforming growth factor-beta 1 knockout mice: A mutation in one cytokine gene causes a dramatic inflammatory disease Am J Pathol 143 1993 3 9
29. M.M. Shull, I. Ormsby, A.B. Kier, and et al. Targeted disruption of the mouse transforming growth factor-beta 1 gene results in multifocal inflammatory disease Nature 359 1992 693 699
30. L. Wu, J. Chau, R.P. Young, and et al. Transforming growth factor-beta1 genotype and susceptibility to chronic obstructive pulmonary disease Thorax 59 2004 126 129
31. A.R. Pons, J. Sauleda, A. Noguera, and et al. Decreased macrophage release of TGF-beta and TIMP-1 in chronic obstructive pulmonary disease Eur Respir J 26 2005 60 66
32. F.M. Kong, X. Ao, L. Wang, and et al. The use of blood biomarkers to predict radiation lung toxicity: A potential strategy to individualize thoracic radiation therapy Cancer Control 15 2008 140 150
33. F.M. Kong, and S. Wang Nondosimetric risk factors for radiation-induced lung toxicity Semin Radiat Oncol 25 2015 100 109